Top

Supplier of Single-Cell Library Construction Kits

Active

Federal

Response Deadline08/13/2026, 07:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → National Institutes Of Health NidaView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 6

subcontract

Response DeadlineAug 13

Submission deadline

Response Deadline

08/13/2026, 07:00:00 PM UTCin 6 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Health And Human Services → National Institutes Of Health Nida

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Supply of Chromium GEM-X Single Cell 5' Library Construction Kit v3, 16 reactions, for single-cell gene expression analysis.

Similar Contracts

Same NAICS industry code

NAICS: 325412

New

Federal

Supplier of Universal 5' Gene Expression Kits

National Institutes Of Health Nida

POSTED

DEADLINE

Supplier of Feature Barcode Kits for Single-Cell Analysis

National Institutes Of Health Nida

POSTED

DEADLINE

Supplier of Chromium GEM-X Single Cell 5' Chip Kits

National Institutes Of Health Nida

POSTED

DEADLINE

SUPPLY AND DELIVERY OF MEDICAL SUPPLIES

Solicitation # 19RP3826Q0059

The U.S. Department of State through the U.S. Embassy Manila is soliciting quotations for the supply and delivery of medical supplies under solicitation number 19RP3826Q0059, with a NAICS code of 325412. Offerors must submit their proposals electronically by August 10, 2026, at 4:00 p.m. Philippine local time, using MS-Word 2007/2010, MS-Excel 2007/2010, or Adobe Acrobat PDF formats, with individual files not exceeding 10MB; larger submissions must be split into multiple emails each under the size limit. Proposals must be in English and include the completed SF-1449 form, Section I Pricing, Section 5 Representations and Certifications, and any additional requirements outlined in Section 3 of the solicitation. All offerors must be registered in the System for Award Management (SAM) prior to submission, as mandated by FAR 4.1102, and failure to register will result in non-responsibility determination. Questions regarding the solicitation must be submitted in writing to ManilaContracting@state.gov no later than July 17, 2026, at 4:00 p.m. Philippine local time. The government intends to award a contract to the responsible vendor submitting the lowest priced acceptable offer, potentially holding discussions only if necessary. No details on delivery schedules, inspection criteria, packaging specifications, or evaluation factors are provided in the available documentation.

POSTED

DEADLINE

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

Solicitation # HT9402-26-Q-9402

The Department of War, through the Defense Health Agency, is soliciting quotes under RFQ HT9402-26-Q-9402 to support the establishment and maintenance of the Uniform Formulary for the Military Health System, as mandated by 10 U.S.C. § 1074g and 32 CFR § 199.21. The process involves evaluating pharmaceutical agents for clinical and cost effectiveness to determine placement on the Uniform Formulary as generic, formulary, Basic Core Formulary, Extended Core Formulary, or non-formulary, with the goal of optimizing pharmaceutical procurement through Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program Agreements. Four newly approved drugs—Awiqli Flextouch (basal insulin), Cavhanza (BCR-ABL tyrosine kinase inhibitor for leukemia and lymphoma), Lipfendra (PCSK9 antilipidemic), and Trutakna (nephrology agent)—are scheduled for review at the November 2026 Pharmacy and Therapeutics Committee meeting, and industry responses will inform their inclusion or exclusion. Responses to the RFQ are due by August 27, 2026, with a pre-quotation teleconference scheduled for August 12, 2026, to clarify requirements. Clinical data submissions for evaluation must be sent via email to the designated point of contact by the deadline specified in Part 2.3.2. The solicitation, issued by the Defense Health Agency under NAICS code 325412, is managed from Aurora, Colorado, with performance centered in San Antonio, Texas. Primary contact is Julia Trang, with Stephanie Erpelding as secondary contact, and all submissions and inquiries must adhere to the instructions outlined in RFQ HT9402-26-Q-9402 to be considered valid.

Defense Health Agency

POSTED

DEADLINE

RABORAL VRG RACCOON BAITS, COATED SACHETS

Solicitation # 1171341

The U.S. Department of Agriculture’s Wildlife Services is seeking to procure up to 6,965,000 units of RABORAL V-RG oral rabies vaccine baits for use during 2026 and 2027, with the sole purpose of controlling rabies in wildlife populations. Only two bait types are authorized for use in the United States: the coated sachet and the fishmeal polymer, both manufactured by Boehringer-Ingelheim Animal Health USA and containing the same live recombinant vaccine that uses an attenuated Vaccinia virus to deliver the rabies glycoprotein gene. The vaccine is incapable of causing rabies but effectively stimulates antibody production in target carnivore species when administered in proper dosage. Each bait is labeled with clear identification and a toll-free information number to assist the public. To ensure readiness for urgent outbreaks, the contract includes provisions for the government to purchase and store a limited supplemental supply beyond standard operational needs. The contract is a firm fixed price IDIQ with a one-year term, allowing for on-demand ordering during the period. All shipments must be delivered FOB destination to specified locations within the contiguous United States, with exact addresses coordinated post-award. The solicitation number is 1171341, with bids due by September 7, 2026, and submissions must be sent exclusively to todd.k.bierl@usda.gov. Late responses will not be accepted, and all proposals are limited to no more than 100 pages. The contracting office is part of APHIS’s Emergency Acquisition Marketing and Regulatory Program Business under the Animal and Plant Health Inspection Service, with Todd K. Bierl serving as the primary point of contact for all inquiries and submissions.

POSTED

DEADLINE

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

Solicitation # HT9402-26-Q-9401

The Department of War, through the Defense Health Agency, is soliciting quotations to support the establishment and maintenance of the Uniform Formulary for the Military Health System, as mandated by federal law and regulation. The process involves evaluating pharmaceutical agents for clinical and cost effectiveness to determine their placement on the formulary tiers—generic, formulary, Basic Core Formulary, Extended Core Formulary, or non-formulary—with the goal of optimizing patient access and managing expenditures. The solicitation includes the potential award of Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program Agreements contingent upon the Pharmacy and Therapeutics Committee’s recommendations. Two drug classes are under review for the November 2026 meeting: Atopy—Topical Agents including Anzupgo, Eucrisa, Opzelura, Vtama, and Zoryve; and Lung Cancer—METEX14, including Tabrecta and Tepmetko. The request for quotation, identified as HT9402-26-Q-9401, outlines detailed procedures, appendices for BPA and ADP, and key submission deadlines. Responses are required by October 1, 2026, with a mandatory pre-quotation teleconference scheduled for August 12, 2026. The solicitation is issued by the Defense Health Agency under the Department of Defense, with the primary point of contact located in Aurora, Colorado, and performance expected in Texas. Vendors must adhere strictly to the instructions provided in the RFQ to ensure eligibility for consideration under the uniform formulary program, which directly impacts pharmacy benefits for military personnel and their dependents.

Defense Health Agency

POSTED

DEADLINE

Pharmaceutical Supply – Albuterol Sulfate Inhalation Aerosol

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing and Supply – Oral ContraceptivesThe contract calls for the manufacture and supply of FDA-approved oral contraceptive tablets containing Norethindrone and Ethinyl Estradiol, USP, meeting a minimum 36-month shelf life and adhering to current good manufacturing practices. The product must also comply with military preservation standards to ensure stability and integrity under field conditions. Production and packaging are required to align with cGMP regulations and the specific demands of the Department of Defense supply chain, with the intended delivery point being APO, ZIP 96543-4010. This is a subcontract opportunity issued under NAICS code 325412, targeting manufacturers capable of consistent, high-volume production for federal procurement. Responses must be submitted by August 11, 2026, following the solicitation issued by the Medical Supply Chain Pharm FSA, which operates under the Department of Defense. All parties must be prepared to meet stringent quality, documentation, and logistical requirements to fulfill military-grade distribution needs.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Fluorescein Sodium Ophthalmic StripsThe contract solicits the manufacture and delivery of Fluorescein Sodium Ophthalmic Strips that comply with FDA regulations and are packaged in sealed unit containers to meet strict military standards for packaging, labeling, and shelf-life. These strips are intended for ophthalmic use and must adhere to the Department of Defense’s specifications for quality, sterility, and longevity under operational conditions. The product will be delivered to Fort Drum, New York, with all packaging and documentation aligned to military logistics and traceability requirements. This is a subcontract issued under NAICS code 325412, which pertains to pharmaceutical preparation manufacturing, and was posted on August 5, 2026, with responses due by August 11, 2026. The contracting activity is managed by the Medical Supply Chain Pharm FSA under the Department of Defense, indicating this is part of a broader defense medical supply initiative. All bidders must ensure full compliance with federal pharmaceutical and defense packaging regulations, and deliveries must be timed to meet operational readiness schedules at the specified location.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Medical and Pharmaceutical Packaging and Marking ServicesThe contract seeks to provide packaging, labeling, and marking services for pharmaceutical and medical supplies in strict compliance with Medical Marking Standard No. 1 and MIL-STD-2073-1E, ensuring all documentation, markings, and packaging meet federal military and healthcare requirements. Services must be performed at the designated place of performance in Williamsburg, Virginia, with ZIP code 23185, and the work falls under NAICS code 325412, which classifies pharmaceutical and medicine manufacturing. This is a subcontract opportunity issued by the Department of Defense through the Medical Supply Chain Pharm FSA, with a response deadline of August 11, 2026, and posted on August 5, 2026. All submissions must adhere to the stringent standards governing the handling and presentation of medical and pharmaceutical items for defense logistics, and bidders are expected to demonstrate proven expertise in defense-compliant packaging procedures.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Veterinary Pharmaceutical Tablet SupplierThe contract requires the manufacture and supply of Maropitant Citrate 160mg veterinary tablets packaged in blister packs containing four tablets per sheet, fully compliant with FDA and Defense Logistics Agency specifications. The product must meet all regulatory and quality standards for veterinary use, with strict adherence to packaging, labeling, and stability requirements to ensure efficacy and safety during storage and transport. The supplier is expected to deliver consistent, high-quality output in accordance with pharmaceutical manufacturing best practices, and all materials must be traceable and documented to support federal procurement compliance. This subcontract is issued under the Medical Supply Chain Pharm FSA, a division of the Department of Defense, with performance required at the APO ZIP code 09227-0000. The solicitation was posted on August 5, 2026, and responses are due by August 11, 2026, indicating a tight turnaround for proposals. The NAICS code 325412 identifies this as a pharmaceutical and biological product manufacturing contract, emphasizing the technical and regulatory expertise necessary for participation. While no set-aside details are provided, the contract is open to qualified subcontractors capable of meeting DoD’s stringent pharmaceutical supply chain requirements, with all deliverables aligned to ensure uninterrupted availability of critical veterinary medications for military and associated personnel.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days

View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida

Same awarding agency

NAICS: 334516

New

Federal

Repair and Installation services for the Heat Exchanger System on a Bruker 9.4 Tesla Magnetic Resonance Imaging (MRI) system

Solicitation # 75N98026Q00967

The National Institutes of Health, National Institute on Drug Abuse’s Intramural Research Program is conducting market research to identify qualified sources capable of providing emergency repair parts and installation services for the Triple-loop Heat Exchanger System on its Bruker 9.4 Tesla Magnetic Resonance Imaging scanner, which has failed and requires immediate replacement to prevent catastrophic magnet quenching. The requirement specifies a brand-name or equal heat exchanger that must interface seamlessly with the existing scanner software, building water supply, magnet cryomech, gradient, and shim coil cooling systems while ensuring stable cryomech operation and maintaining magnet pressure at 1040 mbar. All components must be new, unused, original equipment manufacturer parts authorized by Bruker Corporation, and installation must be performed exclusively by Bruker-certified technicians to preserve the MRI system’s existing warranty. The contractor must deliver and install the system within three months of order receipt, with a one-year warranty covering all parts, labor, travel, and including one preventative maintenance visit. Responses to this sources-sought notice must be submitted electronically by August 12, 2026, and must include detailed capability statements addressing each technical requirement separately, with supporting documentation on company size status under NAICS Code 334516, employee count, personnel qualifications, relevant government contracts, and complete contact and SAM.gov registration information including UEI and TIN. The notice explicitly states that no award will result from this action and that responses are not proposals or quotations. Companies must identify the place of manufacturing and confirm compliance with the Non-Manufacturer Rule if applicable. Proprietary or sensitive data should not be included, though any claimed proprietary information will be safeguarded. Responses are limited to ten pages excluding cover page and references, must reference solicitation number 75N98026Q00967SB, and be sent exclusively to Josh Lazarus at josh.lazarus@nih.gov. All respondents must have an active SAM.gov registration, and while small businesses are strongly encouraged to respond, the government retains full discretion on whether to pursue a competitive or non-competitive acquisition path based on the feedback received.

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

Solicitation # 75N98026Q00962SB

The National Institutes of Health, through the National Institute on Drug Abuse, is seeking information regarding the dCODE Dextramer® product under solicitation number 75N98026Q00962SB, with a response deadline of August 13, 2026 at 7:00 PM Eastern Time. This sources-sought notice, posted on August 6, 2026, aims to gather market capabilities and capabilities from potential suppliers to support research activities within the biomedical and life sciences domain, classified under NAICS code 334516 for medical and dental instruments and supplies. The solicitation is issued by the Office of the Director within the Department of Health and Human Services, located in Bethesda, Maryland, with no set-aside designation specified. Primary point of contact is Scott Duernberger, reachable at 301-594-0670 or scott.duernberger@nih.gov, with secondary support available from Kelly Dempsey. The place of performance has not been designated, and all responses must be submitted through the SAM.gov platform using the provided UI link.

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

Solicitation # 75N98026Q00962

The National Institutes of Health, through the National Institute on Drug Abuse within the Department of Health and Human Services, has issued a sources sought notice with solicitation number 75N98026Q00962 for dCODE Dextramer® technology. This notice, posted on August 6, 2026, seeks information from potential vendors to determine market availability and capabilities related to the specified product, with responses due by August 13, 2026, at 7:00 PM Eastern Time. The North American Industry Classification System code 334516 indicates this is related to surgical and medical instrument manufacturing. All correspondence and inquiries should be directed to Scott Duernberger, the primary point of contact, at scott.duernberger@nih.gov or 301-594-0670, with Kelly Dempsey available as a secondary contact. The contract will be administered from the agency’s office located in Bethesda, Maryland, 20892, though the specific place of performance has not yet been defined. The notice is intended to gather industry feedback to inform future procurement decisions and does not constitute a solicitation for offers or a commitment to award a contract.

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

Repair and Installation services for the Heat Exchanger System on a Bruker 9.4 Tesla Magnetic Resonance Imaging (MRI) system

Solicitation # 75N98026Q00967SB

The National Institute on Drug Abuse within the National Institutes of Health is conducting market research to identify qualified small business sources capable of providing an emergency replacement Triple-loop heat exchanger system and associated installation services for its Bruker 9.4 Tesla MRI scanner. The system is critical to maintaining stable operating conditions for the magnet and preventing a catastrophic quench, which could permanently disable the equipment. The requirement specifies that all parts must be new, unused, original equipment manufacturer components authorized by Bruker Corporation, and installation must be performed exclusively by Bruker-certified technicians to ensure the existing manufacturer’s warranty remains intact. The solution must interface seamlessly with the existing scanner software, utilize the building’s current water supply, and support the cryomech, gradient, and shim coil cooling systems under high-demand imaging conditions, maintaining magnet pressure at 1040 mbar and preventing temperature overloads. Respondents must submit a capability statement of no more than ten pages that demonstrates their ability to meet each technical requirement, including evidence of authorization to supply genuine Bruker parts and certification of installation personnel. Companies must clearly state their small business status under NAICS code 334516, provide their Unique Entity ID and Taxpayer Identification Number, and confirm active SAM.gov registration. Responses must include details on employee count, personnel qualifications, any existing government contracts, and full contact information for technical and administrative points of contact. For equipment, the country of manufacture and place of production must be disclosed, and manufacturers must address compliance with the Non-Manufacturer Rule. The government will not honor confidentiality for proprietary data unless explicitly labeled, and no obligation to award a contract is implied. All submissions are due by August 12, 2026, at 3:00 p.m. EST via electronic submission only to the designated Contracting Officer, with no exceptions for fax or mail. Participation in this sources-sought notice does not constitute a solicitation and will not be acknowledged or evaluated for award purposes.

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

Solicitation # 75N98026Q00960SB

The National Institutes of Health Nida, under the Department of Health and Human Services, is seeking information on potential sources for Chromium Consumables under solicitation number 75N98026Q00960SB. This sources-sought notice, posted on August 6, 2026, invites industry input to support future procurement planning and does not constitute a request for proposals or a commitment to award a contract. Responses are due by August 13, 2026, at 7:00 PM Eastern Time, and the action is classified under NAICS code 334516, which pertains to Semiconductor and Related Device Manufacturing. The office responsible for this effort is located in Bethesda, Maryland, with the primary point of contact being Scott Duernberger, reachable at 301-594-0670 or scott.duernberger@nih.gov, and secondary contact Kelly Dempsey at kelly.dempsey@nih.gov. No set-aside type has been designated, and while the place of performance details are not specified, all responses should be directed through the SAM.gov workspace link provided.

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

Solicitation # 75N98026Q00960

The National Institutes of Health Nida, under the Department of Health and Human Services, has issued a sources sought notice for Chromium Consumables with solicitation number 75N98026Q00960, posted on August 6, 2026, and with a response deadline of August 13, 2026 at 7:00 PM Eastern Time. This action falls under NAICS code 334516 and is directed toward identifying potential suppliers capable of providing the specified consumables, with no set-aside designation indicated. The solicitation is managed from the agency’s office located in Bethesda, Maryland, 20892, and there is no designated place of performance specified beyond the agency’s location. Primary point of contact is Scott Duernberger, reachable at 301-594-0670 or scott.duernberger@nih.gov, with Kelly Dempsey available as a secondary contact at kelly.dempsey@nih.gov. Interested parties should refer to the official SAM.gov link for additional details and submission requirements.

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

Tecan Fluent 780 Robotic Liquid Handler Purchase

Solicitation # 75N98026Q00955

The National Institutes of Health, through the National Library of Medicine, is seeking information from small businesses regarding the availability and capability of suppliers to provide a Tecan Fluent 780 Robotic Liquid Handler with the Te-Chrome module, classified under NAICS code 334516 for Analytical Laboratory Instrument Manufacturing. This sources sought notice is not a solicitation for proposals or quotes but aims to assess the market landscape to determine whether the acquisition can be set aside for small businesses, including HUBZone, service-disabled veteran-owned, 8(a), woman-owned, or small disadvantaged businesses. The government is particularly interested in identifying qualified small business manufacturers or authorized distributors capable of delivering the system within 30 days of order placement to support high-throughput purification and screening of fold-switching proteins critical to autoimmune disease, cancer, and viral pathogenesis research. Respondents must provide detailed information demonstrating how their product meets the technical requirements outlined in Attachment A, along with product literature, capability statements, and confirmation of their business size classification under the NAICS code. Each response must include the company’s DUNS number, full organizational details, technical and administrative points of contact with telephone and email, and explicit statement of their small business status and type. Responses must be submitted electronically by August 11, 2026, to Kevin Alvarez at kevin.alvarez@nih.gov and must not contain any proprietary, classified, or sensitive information. The government explicitly states it will not pay for responses, will not acknowledge receipt, and is under no obligation to award a contract based on this notice, but will use the collected data to shape a future procurement strategy, potentially leading to a presolicitation synopsis and formal solicitation on SAM.gov.

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

Administrative & Technical Support StaffingThe contract titled Administrative & Technical Support Staffing is a subcontract opportunity under the National Institutes of Health NIDA, part of the Department of Health and Human Services, seeking providers to supply administrative assistants, project managers, and technical support personnel. These staff will be responsible for managing documentation, scheduling, reporting, and contract administration tasks essential to the effective operation of federal programs. The NAICS code 561410 indicates the services fall under office administrative services, emphasizing high-volume clerical, organizational, and logistical support functions. The solicitation was posted on August 4, 2026, with a response deadline of August 10, 2026, and no set-aside designation is specified, meaning all eligible businesses may respond. Performance location details are not provided, but work is expected to support NIDA operations, likely at federal facilities or remotely. Interested parties must submit proposals through the SAM.gov portal by the stated deadline.

Document Preparation Services

POSTED

DEADLINE

Construction Safety & Pre-Project Risk ManagementThe contract titled Construction Safety & Pre-Project Risk Management requires the performance of comprehensive safety reviews for construction and renovation projects under the National Institutes of Health Nida, part of the Department of Health and Human Services. The primary responsibility involves identifying and evaluating hazards associated with project activities and ensuring full compliance with OSHA 1926 regulations prior to any project initiation. This work is critical to maintaining workplace safety and preventing incidents by enforcing federal safety standards before operations begin. The contract is classified as a subcontract under NAICS code 541620, which corresponds to environmental consulting services, indicating a focus on professional safety and risk assessment expertise. The solicitation was posted on August 4, 2026, with a response deadline of August 10, 2026, at 1:00 PM, leaving a narrow window for submission. The place of performance and organizational address details are not specified, suggesting that work may occur across multiple sites under the agency’s jurisdiction. There is no set-aside designation provided, meaning the contract is open to all eligible subcontractors regardless of business size or ownership characteristics. The absence of a point of contact may require potential responders to rely on the official SAM.gov portal for further inquiries or documentation requirements.

Environmental Consulting Services

POSTED

3 days ago

DEADLINE

in 3 days

View Details